Study of a new device for leaky mitral valve repair
Part of Digestive system clinical trials.
This trial tests a new device (DragonFly M2) to fix a leaky mitral valve. It's for people with moderate to severe or severe chronic mitral regurgitation who may be able to have the procedure done through a vein in the leg.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a moderate to severe or severe leaking mitral valve (chronic mitral regurgitation), confirmed by an ultrasound of your heart.
- Your doctor thinks it's possible to reach your mitral valve with a thin tube inserted through a vein in your leg.
- You understand the study and agree to take part by signing a consent form.
- You have no masses, blood clots, or growths on your heart valves seen on ultrasound.
- You do not have other serious heart valve problems that need surgery, and you have not had prior surgery or a catheter procedure on your mitral valve.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called HighLife Clarity for people with severe leakage of the mitral valve (a heart valve). It aims to see if the device can help patients who cannot have standard surgery or other minimally invasive treatments.
This trial tests a device called the Dragonfly system to fix a leaky mitral valve caused by heart muscle problems. It may help people with symptoms like shortness of breath or fatigue from this condition.
This trial tests the safety and effectiveness of a heart procedure that repairs a leaking mitral valve through thin tubes, using the Dragonfly system. It’s for people who have significant mitral valve leak symptoms but are considered high risk for open-heart surgery.
This study tests a catheter-based procedure to treat a leaky mitral valve (either FMR or DMR, depending on the group you’re in). It may help reduce symptoms and improve heart function in people who are sick from valve leakage but are able to undergo this specific approach.
This trial tests a catheter-based procedure (putting a small device through blood vessels) to repair a leaking mitral valve caused by heart muscle problems. It aims to reduce symptoms and improve heart function and safety in people who are still having heart failure symptoms despite standard treatment.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
Hear when a new Mitral Valve (MV) Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.